Dec 15 (Reuters) - Quince Therapeutics Inc QNCX.O:
QUINCE THERAPEUTICS ANNOUNCES LAST PATIENT LAST VISIT IN PHASE 3 NEAT CLINICAL TRIAL IN PATIENTS WITH ATAXIA-TELANGIECTASIA
QUINCE THERAPEUTICS - EXPECTS TOPLINE RESULTS IN Q1 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.